Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hoyer

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Scientific Data|February 12, 2025
Cliopatria - A geospatial database of world-wide political entities from 3400BCE to 2024CEJames S Bennett, Erin Mutch, Andrew Tollefson, et al.
ERJ Open Research|March 22, 2018
The potentially beneficial central nervous system activity profile of ivacaftor and its metabolitesElena K Schneider, Rachel M McQuade, Vincenzo C Carbone, et al.
JMIR Research Protocols|May 3, 2026
Structured Online Support to Inform and Assist Antidepressant Deprescribing in Primary Care: Protocol for a Pragmatic, Randomized Controlled Trial (The WiserAD Trial)Catherine Kaylor-Hughes, Amy Coe, Patty Chondros, et al.
Computational and Structural Biotechnology Journal|December 15, 2018
Mechanistic Insights From Global Metabolomics Studies into Synergistic Bactericidal Effect of a Polymyxin B Combination With Tamoxifen Against Cystic Fibrosis MDR <i>Pseudomonas aeruginosa</i>Maytham Hussein, Mei-Ling Han, Yan Zhu, et al.
Journal of Medicinal Chemistry|August 23, 2013
Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomniaClaudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
IUPHAR/BPS Guide to Pharmacology CITE|December 20, 2021
Orexin receptors in GtoPdb v.2021.3Paul Coleman, Luis de Lecea, Anthony Gotter, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.
British Journal of Pharmacology|November 4, 2014
AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluationDominik Feuerbach, Nicole Pezous, Markus Weiss, et al.
British Journal of Pharmacology|August 9, 2023
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic miceRyan J Keenan, Heather Daykin, Jeremy Metha, et al.
Frontiers in Neuroscience|December 31, 2013
Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptorsGabrielle E Callander, Morenike Olorunda, Dominique Monna, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Scientific Data|February 12, 2025
Cliopatria - A geospatial database of world-wide political entities from 3400BCE to 2024CEJames S Bennett, Erin Mutch, Andrew Tollefson, et al.
ERJ Open Research|March 22, 2018
The potentially beneficial central nervous system activity profile of ivacaftor and its metabolitesElena K Schneider, Rachel M McQuade, Vincenzo C Carbone, et al.
JMIR Research Protocols|May 3, 2026
Structured Online Support to Inform and Assist Antidepressant Deprescribing in Primary Care: Protocol for a Pragmatic, Randomized Controlled Trial (The WiserAD Trial)Catherine Kaylor-Hughes, Amy Coe, Patty Chondros, et al.
Computational and Structural Biotechnology Journal|December 15, 2018
Mechanistic Insights From Global Metabolomics Studies into Synergistic Bactericidal Effect of a Polymyxin B Combination With Tamoxifen Against Cystic Fibrosis MDR <i>Pseudomonas aeruginosa</i>Maytham Hussein, Mei-Ling Han, Yan Zhu, et al.
Journal of Medicinal Chemistry|August 23, 2013
Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomniaClaudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
IUPHAR/BPS Guide to Pharmacology CITE|December 20, 2021
Orexin receptors in GtoPdb v.2021.3Paul Coleman, Luis de Lecea, Anthony Gotter, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.
British Journal of Pharmacology|November 4, 2014
AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluationDominik Feuerbach, Nicole Pezous, Markus Weiss, et al.
British Journal of Pharmacology|August 9, 2023
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic miceRyan J Keenan, Heather Daykin, Jeremy Metha, et al.
Frontiers in Neuroscience|December 31, 2013
Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptorsGabrielle E Callander, Morenike Olorunda, Dominique Monna, et al.
Pageof 16